Evaluasi Komprehensif in silico Profil ADME Aqneursa dan Miplyffa: Strategi Seleksi Senyawa Baru yang Disetujui FDA untuk Terapi Niemann-Pick Tipe C

Annisha Noor Dienna, Chynthia Azhari Utri, Sitti Ainun Hikmah, Novalia Nurbaiti

Abstract


Niemann-Pick disease type C (NPC) is a rare neurodegenerative disorder requiring new therapeutic options, where ADME (Absorption, Distribution, Metabolism, Excretion) profiles are critical for drug development. This study aimed to conduct a comparative in silico prediction of the ADME profiles of two novel FDA-approved compounds, Aqneursa and Miplyffa, as candidate therapies for NPC. The result in silico profiling was developed from the web-based tool, SwissADME, such as physicochemical characteristics, lipophilicity, solubility, pharmacokinetics, and drug-likeness. Aqneursa follows all the key drug-likeness rules (Lipinski, Ghose, Veber, Egan, Muegge), has a low molecular weight (173.21 g/mol), a well-soluble, a high gastrointestinal absorption, and  a balanced lipophilicity (Log P 0.66). In contrast, Miplyffa presented significant pharmacokinetic challenges, including a high molecular weight (505.90 g/mol), extreme hydrophilicity (Log P -0.21), high polarity (TPSA 202.65 Ų), low GI absorption, and multiple violations of drug-likeness criteria. Although both compounds were predicted to be non-substrates of P-glycoprotein and non-inhibitors of major CYP450 enzymes, neither was predicted to cross the blood-brain barrier (BBB). In conclusion, Aqneursa is good for oral drugs and worthy of further development for NPC, whereas Miplyffa requires alternative formulation strategies or structural modifications.


Keywords


ADME; Aqneursa; Miplyffa; NPC

Full Text:

PDF

References


Abdallah, R. M., Hasan, H. E., & Hammad, A. (2024). Predictive modeling of skin permeability for molecules: Investigating FDA-approved drug permeability with various AI algorithms. PLOS Digital Health, 3(4 April). https://doi.org/10.1371/journal.pdig.0000483

Almasri, R., Schultz, H. B., Møller, A., Bremmell, K. E., Garcia-Bennett, A., Joyce, P., & Prestidge, C. A. (2022). Role of Silica Intrawall Microporosity on Abiraterone Acetate Solubilization and in Vivo Oral Absorption. Molecular Pharmaceutics, 19(4), 1091–1103. https://doi.org/10.1021/acs.molpharmaceut.1c00781

Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021). Advances in Oral Drug Delivery. In Frontiers in Pharmacology (Vol. 12). Frontiers Media S.A. https://doi.org/10.3389/fphar.2021.618411

Amin, S., Lestari, N., Shofa Nurfatimah, G., Salma Azhara, R., Novita Siti Ramadhani, T., Santika, M., Studi Farmasi, P., & Bakti Tunas Husada, U. (2025). Modifikasi Molekul Kiimia Senyawa Aktif dari Tanaman Obat Sebagai AntiMalaria. http://journal.universitaspahlawan.ac.id/index.php/ners

Bajracharya, R., Song, J. G., Back, S. Y., & Han, H. K. (2019). Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery. In Computational and Structural Biotechnology Journal (Vol. 17, pp. 1290–1308). Elsevier B.V. https://doi.org/10.1016/j.csbj.2019.09.004

Banks, W. A., Engelke, K., Hansen, K. M., Bullock, K. M., & Calias, P. (2019). Modest blood-brain barrier permeability of the cyclodextrin kleptose: Modification by efflux and luminal surface binding. Journal of Pharmacology and Experimental Therapeutics, 371(1), 121–129. https://doi.org/10.1124/jpet.119.260497

Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022). Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. In Biomedicines (Vol. 10, Issue 9). MDPI. https://doi.org/10.3390/biomedicines10092055

Caldwell, N., Peet, C., Miller, P., Colon, B. L., Taylor, M. G., Cocco, M., Dawson, A., Lukac, I., Teixeira, J. E., Robinson, L., Frame, L., Seizova, S., Damerow, S., Tamaki, F., Post, J., Riley, J., Mutter, N., Hanna, J. C., Ferguson, L., … Pawlowic, M. C. (2024). Cryptosporidium lysyl-tRNA synthetase inhibitors define the interplay between solubility and permeability required to achieve efficacy. Science Translational Medicine, 16(770). https://doi.org/10.1126/scitranslmed.adm8631

Coimbra, J. T. S., Feghali, R., Ribeiro, R. P., Ramos, M. J., & Fernandes, P. A. (2020). The importance of intramolecular hydrogen bonds on the translocation of the small drug piracetam through a lipid bilayer. RSC Advances, 11(2), 899–908. https://doi.org/10.1039/d0ra09995c

ElFar, O. A., Billa, N., Lim, H. R., Chew, K. W., Cheah, W. Y., Munawaroh, H. S. H., Balakrishnan, D., & Show, P. L. (2022). Advances in delivery methods of Arthrospira platensis (spirulina) for enhanced therapeutic outcomes. In Bioengineered (Vol. 13, Issue 6, pp. 14681–14718). Taylor and Francis Ltd. https://doi.org/10.1080/21655979.2022.2100863

Guillot, A. J., Jornet-Mollá, E., Landsberg, N., Milián-Guimerá, C., Montesinos, M. C., Garrigues, T. M., & Melero, A. (2021). Cyanocobalamin ultraflexible lipid vesicles: Characterization and in vitro evaluation of drug-skin depth profiles. Pharmaceutics, 13(3). https://doi.org/10.3390/pharmaceutics13030418

Gupta, S., Kesarla, R., & Omri, A. (2013). Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems. ISRN Pharmaceutics, 2013, 1–16. https://doi.org/10.1155/2013/848043

Hamed, R., Eyal, A. D., Berman, E., & Eyal, S. (2023). In silico screening for clinical efficacy of antiseizure medications: Not all central nervous system drugs are alike. In Epilepsia (Vol. 64, Issue 2, pp. 311–319). John Wiley and Sons Inc. https://doi.org/10.1111/epi.17479

Hemmerich, J., & Ecker, G. F. (2020). In silico toxicology: From structure–activity relationships towards deep learning and adverse outcome pathways. In Wiley Interdisciplinary Reviews: Computational Molecular Science (Vol. 10, Issue 4). Blackwell Publishing Inc. https://doi.org/10.1002/wcms.1475

Joseph, T. M., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M. S., Kattali, M., Haponiuk, J., & Thomas, S. (2023). Nanoparticles: Taking a Unique Position in Medicine. In Nanomaterials (Vol. 13, Issue 3). MDPI. https://doi.org/10.3390/nano13030574

Keller, L. A., Merkel, O., & Popp, A. (2022). Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Delivery and Translational Research, 12(4), 735–757. https://doi.org/10.1007/s13346-020-00891-5

Lee, B. L., Kuczera, K., Lee, K. H., Childs, E. W., & Jas, G. S. (2022). Unassisted N-acetyl-phenylalanine-amide transport across membrane with varying lipid size and composition: kinetic measurements and atomistic molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 40(4), 1445–1460. https://doi.org/10.1080/07391102.2020.1827037

Lee, M. K. (2020). Liposomes for enhanced bioavailability of water-insoluble drugs: In vivo evidence and recent approaches. In Pharmaceutics (Vol. 12, Issue 3). MDPI AG. https://doi.org/10.3390/pharmaceutics12030264

Lu, C. T., Zhao, Y. Z., Wong, H. L., Cai, J., Peng, L., & Tian, X. Q. (2014). Current approaches to enhance CNS delivery of drugs across the brain barriers. In International Journal of Nanomedicine (Vol. 9, Issue 1, pp. 2241–2257). Dove Medical Press Ltd. https://doi.org/10.2147/IJN.S61288

O’Shea, J. P., Augustijns, P., Brandl, M., Brayden, D. J., Brouwers, J., Griffin, B. T., Holm, R., Jacobsen, A. C., Lennernäs, H., Vinarov, Z., & O’Driscoll, C. M. (2022). Best practices in current models mimicking drug permeability in the gastrointestinal tract - An UNGAP review. European Journal of Pharmaceutical Sciences, 170. https://doi.org/10.1016/j.ejps.2021.106098

Pisani, L., Farina, R., Soto-Otero, R., Denora, N., Mangiatordi, G. F., Nicolotti, O., Mendez-Alvarez, E., Altomare, C. D., Catto, M., & Carotti, A. (2016). Searching for multi-targeting neurotherapeutics against Alzheimer’s: Discovery of potent AChE-MAO B inhibitors through the decoration of the 2H-Chromen-2-one structural motif. Molecules, 21(3). https://doi.org/10.3390/molecules21030362

Qin, Z., Jia, M., Yang, J., Xing, H., Yin, Z., Yao, Z., Zhang, X., & Yao, X. (2020). Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: Potential drug-drug interactions. Chinese Medicine (United Kingdom), 15(1). https://doi.org/10.1186/s13020-020-00349-3

Rasmussen, C. L. M., Hede, E., Routhe, L. J., Körbelin, J., Helgudottir, S. S., Thomsen, L. B., Schwaninger, M., Burkhart, A., & Moos, T. (2023). A novel strategy for delivering Niemann-Pick type C2 proteins across the blood–brain barrier using the brain endothelial-specific AAV-BR1 virus. Journal of Neurochemistry, 164(1), 6–28. https://doi.org/10.1111/jnc.15621

Saito, K., Hasegawa-Baba, Y., Sekiya, F., Hayashi, S. mo, Mirokuji, Y., Okamura, H., Maruyama, S., Ono, A., Nakajima, M., Degawa, M., Ozawa, S., Shibutani, M., & Maitani, T. (2017). Japan Flavour and Fragrance Materials Association’s (JFFMA) safety assessment of food-flavouring substances uniquely used in Japan that belong to the class of aliphatic primary alcohols, aldehydes, carboxylic acids, acetals and esters containing additional oxygenated functional groups. In Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment (Vol. 34, Issue 9, pp. 1474–1484). Taylor and Francis Ltd. https://doi.org/10.1080/19440049.2017.1333160

Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (Slns): An advanced drug delivery system targeting brain through bbb. In Pharmaceutics (Vol. 13, Issue 8). MDPI AG. https://doi.org/10.3390/pharmaceutics13081183

Singh, J., & Nayak, P. (2023). pH-responsive polymers for drug delivery: Trends and opportunities. In Journal of Polymer Science (Vol. 61, Issue 22, pp. 2828–2850). John Wiley and Sons Inc. https://doi.org/10.1002/pol.20230403

Sitarska, D., Tylki-Szymańska, A., & Ługowska, A. (2021). Treatment trials in Niemann-Pick type C disease. In Metabolic Brain Disease (Vol. 36, Issue 8, pp. 2215–2221). Springer. https://doi.org/10.1007/s11011-021-00842-0

Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023). The Bioavailability of Drugs—The Current State of Knowledge. In Molecules (Vol. 28, Issue 24). Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/molecules28248038

Tashima, T. (2023). Carrier-Mediated Delivery of Low-Molecular-Weight N-Containing Drugs across the Blood–Brain Barrier or the Blood–Retinal Barrier Using the Proton-Coupled Organic Cation Antiporter. Future Pharmacology, 3(4), 742–762. https://doi.org/10.3390/futurepharmacol3040046

Wang, T., Li, Z., Zhuo, L., Chen, Y., Fu, X., & Zou, Q. (2024). MS-BACL: enhancing metabolic stability prediction through bond graph augmentation and contrastive learning. Briefings in Bioinformatics, 25(3). https://doi.org/10.1093/bib/bbae127

Zheng, Q., Chen, Z. X., Xu, M. B., Zhou, X. L., Huang, Y. Y., Zheng, G. Q., & Wang, Y. (2018). Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood–brain barrier permeability: A preclinical systematic review and meta-analysis. Drug Delivery, 25(1), 1617–1633. https://doi.org/10.1080/10717544.2018.1486471




DOI: https://doi.org/10.37905/jambchem.v8i1.34936

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 Jambura Journal of Chemistry



EDITORIAL OFFICE

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.